Polymers,
Journal Year:
2024,
Volume and Issue:
16(23), P. 3260 - 3260
Published: Nov. 23, 2024
There
is
a
shortage
in
the
experimental
research
directly
comparing
effectiveness
of
different
nanoparticles
boosting
asparaginase
(ASNase)
activity.
This
study
assessed
impact
various
on
enhancing
ASNase
activity,
stability,
and
anticancer
effects
through
immobilization.
Journal of Nanotheranostics,
Journal Year:
2025,
Volume and Issue:
6(1), P. 4 - 4
Published: Jan. 31, 2025
Regrettably,
despite
undeniable
advances
in
cancer
diagnosis
and
therapy,
primary
brain
(or
cancer)
remains
one
of
the
deadliest
forms
malignant
tumors,
where
glioblastoma
(GBM)
is
known
as
most
diffuse
glioma
astrocytic
lineage.
Fortunately,
to
improve
this
scenario,
remarkable
progress
nanotechnology
has
brought
new
promise
raised
expectations
treatment.
Nanomedicine,
principally
an
area
amalgamating
with
biology
medicine,
demonstrated
a
pivotal
role,
starting
earliest
detection
while
also
offering
novel
multimodal
therapy
alternatives.
In
vast
realm
nanotechnology,
nanozymes,
type
nanomaterial
intrinsic
enzyme-like
activities
characteristics
connecting
fields
nanocatalysts,
enzymology,
biology,
have
emerged
powerful
nanotools
for
theranostics.
Hence,
fascinating
field
research
experienced
exponential
growth
recent
years.
As
it
virtually
impossible
cover
all
literature
on
broad
domain
science
paper,
review
focuses
presenting
multidisciplinary
approach,
its
content
extending
from
fundamental
knowledge
nanozymes
enzyme-mimicking
catalysis
targeting
cancers.
Although
we
are
at
very
early
stages
research,
can
be
envisioned
that
strategic
development
theranostics
will
positively
offer
disruptive
nanoplatforms
future
nano-oncology.
Journal of Materials Chemistry B,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Nanocatalytic
medicine
for
treating
cancer
requires
effective,
versatile
and
novel
tools
approaches
to
significantly
improve
the
therapeutic
efficiency
interactions
of
(non-)enzymatic
reactions.
However,
it
is
necessary
develop
nanotechnologies
capable
selectively
killing
tumour
cells
without
harming
normal
cells.
Their
characteristics
should
be
adaption
tumours'
extra-
intracellular
environment
being
specifically
active.
To
contribute
this
common
goal,
we
propose
use
pH-
redox-responsive
ferrocene
containing
polymersomes
(FcPsomes).
This
allows
regulation
their
biological
activities
controlled
production
radicals
Chemistry & Biodiversity,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 23, 2024
The
nanozymes
(NZs)
are
the
artificial
catalyst
deployed
for
biosensing
with
their
uniqueness
(high
robustness,
surface
tenability,
inexpensive,
and
stability)
obtaining
a
better
response/miniaturization
of
varied
sensors
than
traditional
ancestors.
Nowadays,
nanomaterials
broadened
scale
such
as
metal-organic
frameworks
(MOFs),
metals/metal
oxides
widely
engaged
in
generating
NZ-based
biosensors
(BS).
Diverse
strategies
like
fluorescent,
colorimetric,
surface-enhanced
Raman
scattering
(SERS),
electrochemical
sensing
principles
were
implemented
signal
transduction
NZs.
Despite
broad
advantages,
numerous
encounters
(like
specificity,
feasibility,
stability,
issues
scale-up)
affecting
potentialities
NZs-based
BS,
thus
need
prior
attention
promising
exploration
revolutionary
outcome
advanced
theranostics.
This
review
includes
different
types
NZs,
progress
NZs
tailored
bio-sensing
techniques
detecting
abundant
bio
analytes
theranostic
purposes.
Further,
discussion
highlighted
some
recent
challenges
along
progressive
way
possibly
overcoming
followed
by
commercial
outbreaks.